Implementing an intravenous insulin infusion protocol in the intensive care unit

American Journal of Health-System Pharmacy

Volumn 64, Issue 4, 2007, Pages 385-395

  Rea, Rhonda S ^a,b,c   Donihi, Amy Calabrese ^c   Bobeck, MaryBeth ^d   Herout, Peter ^e   McKaveney, Teresa P ^c   Kane Gill, Sandra L ^f   Korytkowski, Mary T ^g,h,i  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c UP ^*  (United States)

^d NEW HANOVER REGIONAL MEDICAL CENTER   (United States)

^e ADVOCATE CHRIST MEDICAL CENTER   (United States)

^f Center for Pharmacoinformatics and Outcomes Research   (United States)

^g Division of Endocrinology   (United States)

^h UP   (United States)

ⁱ UP Medical Center Diabetes Patient Safety Committee

Author keywords

Hospitals; Injections; Insulin; Insulins; Pharmacists, hospital; Physicians; Protocols; Workload

Indexed keywords

INSULIN;

ALGORITHM; ARTICLE; CLINICAL PROTOCOL; DRUG DOSE INCREASE; GLYCEMIC CONTROL; HOSPITAL PERSONNEL; HOSPITAL PHYSICIAN; HUMAN; INDEPENDENCE; INSULIN INFUSION; INTENSIVE CARE UNIT; NURSING STAFF; OUTCOME ASSESSMENT; PHARMACIST; PRIORITY JOURNAL; UNITED STATES; UNIVERSITY HOSPITAL; WORKLOAD;

EID: 33847101914     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp060014     Document Type: Article

References (31)

1. Clement S, Braithwaite SS, Magee MF et al. Management of diabetes and hyperglycemia in hospitals. Diabetes Care. 2004; 27:553-91.
2. Krinsley JS. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc. 2003; 78:1471-8.
3. Van Den Berghe G, Wouters P, Weckers F et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001; 345:1359-67.
4. Van Den Berghe G. Insulin in the ICU. ADA 65th Scientific Sessions. San Diego, CA; 2005 Jun 12. Abstract.
5. Davies RR, Newton RW, McNeill GP et al. Metabolic control in diabetic subjects following myocardial infarction. Scott Med J. 1991; 36:74-6.
6. Malmberg K, Ryden L, Efendic S et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study). J Am Coll Cardiol. 1995; 26:57-65.
7. Wall RJ, Dittus RS, Ely EW. Protocol-driven care in the intensive care unit: a tool for quality. Critical Care. 2001; 5:283-5.
8. Lewis KS, Kane-Gill SL, Bobek MB et al. Intensive insulin therapy for critically ill patients. Ann Pharmacother. 2004; 38:1243-51.
9. Chant C, Wilson G, Friedrich JO. Validation of an insulin infusion nomogram for intensive glucose control in critically ill patients. Pharmacotherapy. 2005; 25:352-9.
10. Brown G, Dodek P. Intravenous insulin nomogram improves blood glucose control in the critically ill. Crit Care Med. 2001; 29:1714-9.
11. Zimmerman CR, Mlynarek ME, Jordan JA et al. An insulin infusion protocol in critically ill cardiothoracic surgery patients. Ann Pharmacother. 2004; 38:1123-9.
12. Goldberg PA, Siegel MD, Sherwin RS et al. Implementation of a safe and effective insulin infusion protocol in a medical intensive care unit. Diabetes Care. 2004; 27:461-7.
13. Dimple D, Lannigan J, Pedroff T et al. Insulin infusion protocol for critical care units. Am J Health-Syst Pharm. 2005; 62:2260-4.
14. Byrum D. Why is it so important to treat hyperglycemia in critically ill patients? Crit Care Nurse. 2004; 24:86-9.
15. Van Den Berghe G. Beyond diabetes: saving lives with insulin in the ICU. Int J Obes. 2002; 26(suppl 3):S3-8.
16. Pronovost PJ, Nolan T, Zeger S et al. How can clinicians measure safety and quality in acute care? Lancet. 2004; 363:1061-7.
17. Donihi AC, Rea RS, Dinardo M et al. Development and implementation of an intravenous insulin infusion protocol in the medical intensive care unit. Diabetes. 2005; 54(suppl 1):A116. Abstract.
18. Furney AP, Gao G, Grunkemeier GL et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2003; 125:1007-21.
19. Gadsden RH. Sources of variation in blood glucose testing. In: Challenges in diabetes management/milestone in monitoring. New York: Health Education Technologies; 1998:63-6.
20. Kanji S, Buffie J, Hutton B et al. Reliability of point-of-care testing for glucose measurement in critically ill adults. Crit Care Med. 2005; 33:2778-85.
21. Fuloria M, Friedberg MA, DuRant RH et al. Effect of flow rate and insulin priming on the recovery of insulin from microbore infusion tubing. Pediatrics. 1998; 102:1401-6.
22. Trissel LA. Handbook on injectable drugs. 12th ed. Bethesda, MD: American Society of Health-System Pharmacists; 2003.
23. Van Den Berghe. Beyond diabetes: saving lives with insulin in the ICU. Int J Obes Relat Metab Disord. 2002; 26(suppl 3):S3-8.
24. Curley MA, Kinnen S, Geller M. Venous Arterial Management Protection System product evaluation. J Pediatr Nurs. 1992; 7:67-9.
25. Carlson G. The value of point-of-care testing when instituting an insulin drip protocol. Crit Care Nurs Q. 2001; 24:49-53.
26. Tang Z, Du X, Louie RF et al. Effects of pH on glucose measurements with handheld glucose meters and a portable glucose analyzer for point-of-care testing. Arch Pathol Lab Med. 2000; 124:577-82.
27. Curtis JR, Cook DJ, Wall RJ et al. Intensive care unit quality improvement: a "how-to" guide for the interdisciplinary team. Crit Care Med. 2006; 34:211-8.
28. Goldberg PA, Inzucchi SE. Selling root canals: lessons learned from implementing a hospital insulin infusion protocol. Diabetes Spectrum. 2005; 18:28-33.
29. Abern M, Boland E, Rothenberg DM et al. Intensive insulin therapy (IIT) after coronary artery bypass graft (CABG) surgery. Diabetes. 2004; 53(suppl 2):A116. Abstract.
30. Bode BW, Braithwaite SS, Steed RD et al. Intravenous insulin infusion therapy: indications, methods, and transition to subcutaneous insulin therapy. Endocr Pract. 2004; 10(suppl 2):71-80.
31. Davidson PC, Steed RD, Bode BW. Glucommander: a computer-directed intravenous insulin system shown to be safe, simple, and effective in 120,618 h of operation. Diabetes Care. 2005; 28:2418-23.